Amgen

Results: 561



#Item
371NEW BRUNSWICK DRUG PLANS  FILGRASTIM (NEUPOGEN®) /PEGFILGRASTIM (NEULASTA®) SPECIAL AUTHORIZATION REQUEST FORM New Brunswick Drug Plans / Régimes de médicaments du Nouveau-Brunswick

NEW BRUNSWICK DRUG PLANS FILGRASTIM (NEUPOGEN®) /PEGFILGRASTIM (NEULASTA®) SPECIAL AUTHORIZATION REQUEST FORM New Brunswick Drug Plans / Régimes de médicaments du Nouveau-Brunswick

Add to Reading List

Source URL: www.gnb.ca

Language: English - Date: 2014-07-08 13:06:17
372HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Epogen safely and effectively. See full prescribing information for Epogen. Epogen® (epoetin alfa) injection, for i

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Epogen safely and effectively. See full prescribing information for Epogen. Epogen® (epoetin alfa) injection, for i

Add to Reading List

Source URL: pi.amgen.com

Language: English - Date: 2014-06-20 18:07:12
373OMONTYS (peginesatide) Injection Label

OMONTYS (peginesatide) Injection Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-05 09:13:53
374Amgen-Sponsored Studies  Amgen Countermeasures for Bone and Muscle Loss in Space and on Earth  

Amgen-Sponsored Studies Amgen Countermeasures for Bone and Muscle Loss in Space and on Earth  

Add to Reading List

Source URL: www.astronautical.org

Language: English - Date: 2013-07-28 17:10:21
375Aranesp (Darbepoetin alfa) Label

Aranesp (Darbepoetin alfa) Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-06-24 09:47:22
376Implementing ACD/Automation Server Processing with Micro Flow-Injection and Open-Access NMR Steve Hollis Amgen Inc. Cambridge, MA

Implementing ACD/Automation Server Processing with Micro Flow-Injection and Open-Access NMR Steve Hollis Amgen Inc. Cambridge, MA

Add to Reading List

Source URL: www.acdlabs.com

Language: English - Date: 2014-04-03 09:19:59
377PharmaSUG[removed]Paper DS13  “Analysis-ready” – Considerations, Implementations, and Real World Applications Ellen (Zihui) Lin, Amgen Inc, Thousand Oaks, CA Beiying Ding, Amgen Inc, Thousand Oaks, CA

PharmaSUG[removed]Paper DS13 “Analysis-ready” – Considerations, Implementations, and Real World Applications Ellen (Zihui) Lin, Amgen Inc, Thousand Oaks, CA Beiying Ding, Amgen Inc, Thousand Oaks, CA

Add to Reading List

Source URL: www.pharmasug.org

Language: English - Date: 2012-05-09 22:13:46
378Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-06-04 01:05:55
379Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended

Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended

Add to Reading List

Source URL: www.hma.eu

Language: English - Date: 2010-07-01 10:53:41
380Microsoft Word - SNF Webinar Faxblast[removed]Draft.doc

Microsoft Word - SNF Webinar Faxblast[removed]Draft.doc

Add to Reading List

Source URL: www.amgen.com

Language: English - Date: 2013-10-01 12:19:43